Browse the evidence

There is a lack of studies comparing adverse events across different populations for glucagon-like peptide-1 receptor agonists.

Further research is needed to assess the safety of glucagon-like peptide-1 receptor agonists across diverse populations.

There is an urgent need for fundamental research to understand the mechanisms of metabolic disorders and cardiovascular disease.

Invest in research to better understand and treat metabolic and cardiovascular diseases.

Advances in understanding molecular causes of rare genetic obesities have led to therapies targeting appetite regulation.

Practitioners should consider new therapies targeting appetite regulation for patients with rare genetic obesities.

Emerging therapeutic strategies are focusing on novel targets such as growth differentiation factor 15 (GDF15) and bile acid receptors including the farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5).

Practitioners should stay informed about these novel molecular targets for potential future therapies in obesity management.

Further research is needed to assess the long-term safety of Tirzepatide, particularly regarding cardiovascular outcomes.

Practitioners should be aware of the need for ongoing evaluation of Tirzepatide's long-term safety profile.

Interdisciplinary collaboration and communication between anaesthetists, surgeons, general practitioners, and endocrinologists are required to further investigate and establish preoperative guidelines for safe GLP-1 agonist use.

Healthcare teams should work together to create and follow guidelines for managing patients on GLP-1 agonists in surgical settings.

GLP-1 receptor agonists can exist stably in patients for a long time, overcoming the short half-life of natural GLP-1.

Practitioners can expect longer-lasting effects from GLP-1 receptor agonists compared to natural GLP-1.

Collagen and free amino acid ingestion did not significantly increase myofibrillar protein synthesis rates in either rested or exercised legs.

Collagen and amino acid supplementation may not enhance muscle protein synthesis in healthy individuals post-exercise.

Collagen and free amino acid ingestion did not significantly increase muscle connective protein synthesis rates in either rested or exercised legs.

Collagen and amino acid supplementation may not enhance connective tissue protein synthesis in healthy individuals post-exercise.

62% of protein supplement users were male.

Practitioners should note the gender distribution in protein supplement use.

42% of protein supplement users were aged 25–34.

Targeted educational initiatives can be focused on this age group.

Up to half of patients with diabetes mellitus are undiagnosed when referred for elective surgery.

Healthcare providers should consider screening for diabetes in patients scheduled for elective surgery.

The 2015 law for strengthening health promotion and prevention defines goals for T2D.

Legislators and health organizations should be aware of the defined goals for T2D.

The law does not present strategies or financial and personnel prerequisites for effective primary and secondary prevention.

Health policymakers need to develop strategies and allocate resources for effective prevention.

A fixed-dose drug treatment protocol is recommended for the management of patients in secondary prevention, diabetes, and primary prevention.

Practitioners should implement fixed-dose protocols for managing these patient populations.

Obesity prevalence is projected to grow by 40% in the next decade.

Health professionals should prepare for increased obesity-related health issues.

A BMI greater than 30 kg/m^2 is considered diagnostic for obesity.

Practitioners should use BMI as a key metric for diagnosing obesity.

Glucose is essential for the functioning of the pentose phosphate pathway (PPP) and cannot be substituted by other metabolites.

Practitioners should recognize the critical role of glucose in metabolic processes.

Mean arterial pressure (MAP) remains nearly constant between sodium intakes of 1,200 and 4,000 mg/d.

Practitioners may consider that moderate sodium intake does not significantly impact blood pressure.

The fraction of available calories from protein in the US food supply has decreased by ~1% since the early 1970s.

Awareness of changes in dietary composition over time is important for nutritional guidance.

More people around the world now have obesity than suffer from starvation.

This indicates a need for urgent public health interventions to address obesity.

The energy available in the food supply increased much more than population needs.

This suggests that dietary guidelines may need to be adjusted to account for excess energy availability.

Substantial investments in coordinated nutrition and agricultural research are needed to transform the food system.

This highlights the importance of policy and research in addressing obesity and food security.

The mean cumulative intervention costs for the intensive lifestyle intervention (ILI) were $11,275 per person, compared to $887 for standard diabetes support and education (DSE), resulting in ILI costing $6,666 more per person than DSE.

Practitioners should consider the higher costs associated with intensive lifestyle interventions compared to standard education.